Table of Contents
CHAPTER One: Executive Summary
- Market Drivers
- Market Size and Growth
- Total Transdermal/Transmucosal Drug Delivery Market
- Transdermal/Transmucosal Drug Delivery Only Market
- Competitive and Market Analysis
CHAPTER Two: Introduction and Overview
- Scope and Methodology
- Reasons for Transdermal/Transmucosal Drug Delivery Systems
- History of Transdermal and Transmucosal Drug Delivery
- Phases of Drug Action
- Topical Drug Delivery
- Types of Topical Preparations
- Market Participants
- Transdermal Patch Drug Delivery
- Membrane-Controlled System
- Adhesive Dispersion-Type System
- Matrix Diffusion-Controlled System
- Microreservoir Dissolution-Controlled System
- New Transdermal Drug Applications and Approvals
- Electrotransport Drug Delivery
- Iontophoresis
- Transmucosal Drug Delivery
- Oral Transmucosal Fentanyl Citrate (OTFC)
- Transmucosal Etomidate
- Ondansetron ODT
- Buccal Drug Delivery
- Vaginal Drug Delivery
CHAPTER three: Trends and Developments
- Innovations in Transdermal Drug Delivery
- Adhesive Technology and Issues
- Adhesive Market Issues
- Biotechnological Issues
- Iontophoresis and Sonophoresis
- Developments in Insulin Delivery
- New Developments in Hormone Drug Delivery
- New Mucosal/Buccal Delivery Systems
- Other New Drug Delivery Systems
- Macroflux Technology
- Controlled Thermal Energy Technology
- New Ultrasound Technology
- Combination Delivery Technology
- Transdermal Products in Development
CHAPTER four: Market Size and Growth
- The Total Transdermal/Transmucosal Drug Delivery Market
- Transdermal/Transmucosal Delivery Technology Only Market
CHAPTER five: Competitive Analysis
- Competitive Landscape
- Market Analysis
CHAPTER SIX: Company Profiles
- 3M Pharmaceuticals
- Acrux Limited
- Altea Therapeutics, Inc
- ALZA Corporation
- Antares Pharma, Inc.
- Aveva Drug Delivery Systems
- Cardinal Health
- Cephalon Inc
- Generex Biotechnology Corporation
- Inovio Biomedical Corporation
- Labtec GmbH
- Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
- MacroChem Corporation
- NexMed, Inc.
- Noven Pharmaceuticals, Inc.
- SkyePharma PLC
Appendix
Company Directory
Table of exhibits
CHAPTER two: Introduction and Overview
- Table 2-1: Sequence of Drug Action
CHAPTER three: Trends and Developments
- Table 3-1: Selected Transdermal Products in Development
CHAPTER four: Market Size and Growth
- Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Technology and Pharmaceuticals 2002-2010
- Figure 4-1: The Worldwide Market for Transdermal/Transmucosal Drug
Delivery Technology and Pharmaceuticals 2002-2010
- Table 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/
Transmucosal Drug Delivery Systems by Type 2002-2010
- Figure 4-2: The Worldwide Market for Pharmaceuticals Utilizing
Transdermal/ Transmucosal Drug Delivery Systems Revenues by Type 2002-2010
- Table 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/
Transmucosal Drug Delivery Technologies Market Share by Type 2002-2010
- Figure 4-3: The Worldwide Market for Pharmaceuticals Utilizing
Transdermal/ Transmucosal Drug Delivery Technologies by Type 2006
- Figure 4-4: The Worldwide Market for Pharmaceuticals Utilizing
Transdermal/ Transmucosal Drug Delivery Technologies by Type 2010
- Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Systems by Pharmaceutical and Drug Delivery Component 2002-2010
- Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component
2002-2010
- Figure 4-5: The Worldwide Market for Transdermal/Transmucosal Drug
Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery
Component 2002-2010
- Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug
Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery
Component 2006
- Figure 4-7: The Worldwide Market for Transdermal/Transmucosal Drug
Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery
Component 2010
CHAPTER five: Competitive Analysis
- Table 5-1: Leading Suppliers of Transdermal/Transmucosal Drug Delivery
Technology
|
Related Report
|